Atlas Venture Fund X, L.P. Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Atlas Venture Fund X, L.P..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Atlas Venture Fund X, L.P.. Atlas Venture Fund X, L.P. is a 10% Owner in AVROBIO, Inc. ($AVRO) and a 10% Owner in Magenta Therapeutics, Inc. ($MGTA) and a 10% Owner in Generation Bio Co. ($GBIO) and a 10% Owner in Replimune Group, Inc. ($REPL) and a 10% Owner in Kymera Therapeutics, Inc. ($KYMR) and a 10% Owner in Ikena Oncology, Inc. ($IKNA).
Address: 400 TECHNOLOGY SQ., 10TH FLOOR CAMBRIDGE 02139 MA
Companies in which Atlas Venture Fund X, L.P. is an Insider
AVROBIO, Inc.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Atlas Venture Fund X, L.P.: 10% Owner
Holdings: 5,567,289 shares
Latest Transaction: Jul 23 2019
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Generation Bio Co.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Atlas Venture Fund X, L.P.: 10% Owner
Holdings: 8,111,939 shares
Latest Transaction: Jun 21 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Ikena Oncology, Inc.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Atlas Venture Fund X, L.P.: 10% Owner
Holdings: 2,901,609 shares
Latest Transaction: Apr 01 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Kymera Therapeutics, Inc.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Atlas Venture Fund X, L.P.: 10% Owner
Holdings: 6,885,631 shares
Latest Transaction: Feb 22 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Magenta Therapeutics, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Atlas Venture Fund X, L.P.: 10% Owner
Holdings: 4,117,125 shares
Latest Transaction: Mar 22 2019
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Replimune Group, Inc.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Atlas Venture Fund X, L.P.: 10% Owner
Holdings: 2,486,296 shares
Latest Transaction: Sep 17 2020
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Atlas Venture Fund X, L.P.
Sentiment: All, AVRO, GBIO, IKNA, KYMR, MGTA, REPL
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 21 2021 | GBIO | Generation Bio Co. | Atlas Venture Fund X, L.P. | 10% Owner | Sell | J | 0.00 | 100,000 | 0 | 1,266,937 | 1.4 M to 1.3 M (-7.32 %) |
| Jun 21 2021 | GBIO | Generation Bio Co. | Atlas Venture Fund X, L.P. | 10% Owner | Sell | J | 0.00 | 100,000 | 0 | 1,266,937 | 1.4 M to 1.3 M (-7.32 %) |
| Jun 21 2021 | GBIO | Generation Bio Co. | Atlas Venture Fund X, L.P. | 10% Owner | Sell | J | 0.00 | 1,000,000 | 0 | 8,111,939 | 9.1 M to 8.1 M (-10.97 %) |
| Jun 21 2021 | GBIO | Generation Bio Co. | Atlas Venture Fund X, L.P. | 10% Owner | Sell | J | 0.00 | 1,000,000 | 0 | 8,111,939 | 9.1 M to 8.1 M (-10.97 %) |
| Apr 01 2021 | IKNA | Ikena Oncology, In ... | Atlas Venture Fund X, L.P. | 10% Owner | Option Exercise | C | 0.00 | 5,362,888 | 0 | 0 | |
| Apr 01 2021 | IKNA | Ikena Oncology, In ... | Atlas Venture Fund X, L.P. | 10% Owner | Option Exercise | C | 0.00 | 7,863,094 | 0 | 0 | |
| Apr 01 2021 | IKNA | Ikena Oncology, In ... | Atlas Venture Fund X, L.P. | 10% Owner | Option Exercise | C | 0.00 | 11,258,117 | 0 | 0 |